Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism*; D004347:Drug Interactions; D005951:Glucose Tolerance Test; D006003:Glycogen / Q000378:metabolism*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007515:Islets of Langerhans / Q000187:drug effects*; D008099:Liver / Q000187:drug effects; D008112:Liver Glycogen / Q000378:metabolism; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D010879:Piperazines; D011799:Quinazolines / Q000494:pharmacology*; D052999:Quinazolinones; D051381:Rats; D014044:Tolbutamide / Q000494:pharmacology*
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D010879:Piperazines; D011799:Quinazolines; D052999:Quinazolinones; C008918:centpiperalone; D006003:Glycogen; D014044:Tolbutamide